Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Luoxin Pharmacy to Develop Narrow-Spectrum Antibiotic

publication date: Jun 13, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shandong Luoxin Pharmacy Stock Co. announced it would begin developing cefazedone sodium and cefazedone sodium for injection. Cefazedone is a narrow spectrum antibiotic that is used to treat enterococci, a gram-positive cocci that occurs in the digestive tract. Luoxin says it will be the first manufacturer of the product in China. More details....

Stock Symbol: (HKEX: 8058)     Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



ChinaBio® Events
Suzhou, China
May 18 - 19, 2016
Record attendance of 1008!
See us next year in Shunde!

>> More events...

Other Events
Hong Kong, China
June 15–17, 2016
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors